162 related articles for article (PubMed ID: 12499470)
1. Regulatory and reimbursement issues in treating patients with immune-mediated neuropathies.
Donofrio PD; Busis NA
Neurology; 2002 Dec; 59(12 Suppl 6):S41-5. PubMed ID: 12499470
[TBL] [Abstract][Full Text] [Related]
2. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment in peripheral nerve disorders--indications, mechanisms of action and side-effects.
Hahn AF
Curr Opin Neurol; 2000 Oct; 13(5):575-82. PubMed ID: 11073366
[TBL] [Abstract][Full Text] [Related]
4. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Stangel M; Gold R
Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
[TBL] [Abstract][Full Text] [Related]
5. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
7. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
Trebst C; Brunhorn K; Lindner M; Windhagen A; Stangel M
Eur J Neurol; 2006 Dec; 13(12):1359-63. PubMed ID: 17116220
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment on anti-GM1 antibodies associated neuropathies inhibits cholera toxin and galectin-1 binding to ganglioside GM1.
Peng W
Immunol Lett; 2012 Apr; 143(2):146-51. PubMed ID: 22289946
[TBL] [Abstract][Full Text] [Related]
9. Advances in the use of IVIg in neurological disorders.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():1-2. PubMed ID: 18685918
[No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
11. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
Dalakas MC
J Neurol; 2006 Sep; 253 Suppl 5():V25-32. PubMed ID: 16998751
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin in therapy of peripheral neuropathy.
Gorshtein A; Levy Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):271-9. PubMed ID: 16391402
[TBL] [Abstract][Full Text] [Related]
13. Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.
Raiman S; Knight SE; Eley B; Welzel TB
J Clin Immunol; 2015 Oct; 35(7):668-74. PubMed ID: 26369911
[TBL] [Abstract][Full Text] [Related]
14. Advances in the understanding of the mechanism of action of IVIg.
Hartung HP
J Neurol; 2008 Jul; 255 Suppl 3():3-6. PubMed ID: 18685919
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin: striving for appropriate use.
Kumar A; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies.
Gallia F; Balducci C; Nobile-Orazio E
J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673
[TBL] [Abstract][Full Text] [Related]
17. [Immunoglobulins and physiopathology: actual indications].
Mouthon L; Guilpain P
Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
19. 7th International Immunoglobulin Conference: Neurology.
Nobile-Orazio E; Lewis RA
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):22-4. PubMed ID: 25546749
[TBL] [Abstract][Full Text] [Related]
20. [Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006].
Guillevin L
Rev Med Interne; 2007 May; 28 Spec No. 1():1-3. PubMed ID: 17768830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]